These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 21325806

  • 1. Is conventional urinary cytology still reliable for diagnosis of primary bladder carcinoma? Accuracy based on data linkage of a consecutive clinical series and cancer registry.
    Turco P, Houssami N, Bulgaresi P, Troni GM, Galanti L, Cariaggi MP, Cifarelli P, Crocetti E, Ciatto S.
    Acta Cytol; 2011; 55(2):193-6. PubMed ID: 21325806
    [Abstract] [Full Text] [Related]

  • 2. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C, Chautard D, Devonec M, Perrin P, Chopin D, Rischmann P, Bouchot O, Beurton D, Coulange C, Rambeaud JJ.
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [Abstract] [Full Text] [Related]

  • 3. Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.
    Moonen PM, Kiemeney LA, Witjes JA.
    Eur Urol; 2005 Dec; 48(6):951-6; discussion 956. PubMed ID: 16257108
    [Abstract] [Full Text] [Related]

  • 4. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ.
    Arch Esp Urol; 2002 Dec; 55(1):41-9. PubMed ID: 11957750
    [Abstract] [Full Text] [Related]

  • 5. Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma: a "split-sample" study.
    Sullivan PS, Nooraie F, Sanchez H, Hirschowitz S, Levin M, Rao PN, Rao J.
    Cancer; 2009 Jun 25; 117(3):167-73. PubMed ID: 19365828
    [Abstract] [Full Text] [Related]

  • 6. [Meta-analysis of fluorescence in situ hybridization and cytology for diagnosis of bladder cancer].
    Yang MG, Zhao XK, Hou Y, Xiao N.
    Ai Zheng; 2009 Jun 25; 28(6):655-62. PubMed ID: 19635207
    [Abstract] [Full Text] [Related]

  • 7. Urinary cytology for carcinoma in situ of the urinary bladder.
    Rosa B, Cazin M, Dalian G.
    Acta Cytol; 1985 Jun 25; 29(2):117-24. PubMed ID: 3856981
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer.
    Wiener HG, Vooijs GP, van't Hof-Grootenboer B.
    Acta Cytol; 1993 Jun 25; 37(2):163-9. PubMed ID: 8465635
    [Abstract] [Full Text] [Related]

  • 10. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M, Fahmy M, Brainard JA, Pettay JD, Biscotti CV, Liou LS, Procop GW, Jones JS, Ulchaker J, Zippe CD, Tubbs RR.
    J Urol; 2003 Jun 25; 169(6):2101-5. PubMed ID: 12771727
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
    Hautmann S, Toma M, Lorenzo Gomez MF, Friedrich MG, Jaekel T, Michl U, Schroeder GL, Huland H, Juenemann KP, Lokeshwar VB.
    Eur Urol; 2004 Oct 25; 46(4):466-71. PubMed ID: 15363562
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The value of urine cytology in the diagnosis of recurrent bladder tumors. A preliminary report.
    reichborn-Kjennerud S, Hoeg K.
    Acta Cytol; 1972 Oct 25; 16(3):269-72. PubMed ID: 4503072
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
    Moonen PM, Merkx GF, Peelen P, Karthaus HF, Smeets DF, Witjes JA.
    Eur Urol; 2007 May 25; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.